ATI RN
Pharmacology ATI Final Questions
Question 1 of 5
Which of the following contributes most to the debilitation of an individual during a course of chemotherapy?
Correct Answer: D
Rationale: Pain is a significant contributor to the debilitation of an individual during a course of chemotherapy. The side effects of chemotherapy often include pain, which can be caused by treatment procedures, side effects of medication, or the cancer itself. Pain can lead to decreased mobility, appetite, and overall quality of life, impacting the individual's ability to cope with treatment and recovery. Managing pain effectively is crucial in improving the patient's comfort and overall well-being during chemotherapy. While diarrhea, alopecia, and constipation are common side effects of chemotherapy, they do not typically contribute as significantly to the debilitation of an individual compared to pain.
Question 2 of 5
When the nurse is administering topical nitroglycerin ointment, which technique is correct?
Correct Answer: D
Rationale: The correct technique when administering topical nitroglycerin ointment is to remove the old ointment before applying new ointment. This is important to prevent an accumulation of the medication on the skin, which can lead to an overdose. It is crucial to follow the prescribed instructions for applying topical medications to ensure safe and effective administration.
Question 3 of 5
When assessing a patient who is receiving a loop diuretic, the nurse looks for the manifestations of potassium deficiency, which would include what symptoms? (Select all that apply.)
Correct Answer: D
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 4 of 5
A pregnant woman is experiencing hypertension. The nurse knows that which drug is commonly used for a pregnant patient who is experiencing hypertension?
Correct Answer: D
Rationale: Methyldopa is the preferred antihypertensive medication for pregnant women experiencing hypertension. It has been extensively studied and considered safe for both the mother and the fetus. Methyldopa has been shown to effectively lower blood pressure in pregnant women without causing harm to the developing fetus. Other antihypertensive medications, such as Enalapril (Vasote) and Hydrochlorothiazide (HydroDIURIL), are contraindicated during pregnancy as they can cause harm to the fetus. Mannitol (Osmitrol) is an osmotic diuretic primarily used for reducing intracranial pressure or treating cerebral edema, not for hypertension in pregnancy.
Therefore, Methyldopa is the right choice for a pregnant patient with hypertension.
Question 5 of 5
When a patient is receiving diuretic therapy, which of these assessment measures would best reflect the patient™s fluid volume status?
Correct Answer: C
Rationale: When a patient is receiving diuretic therapy, monitoring intake, output, and daily weight is essential in assessing the patient's fluid volume status. Diuretics promote the excretion of excess fluid from the body, which can lead to changes in fluid balance. Monitoring intake and output provides information about how much fluid the patient is taking in and how much is being excreted, helping to assess the overall fluid balance. Daily weight measurements can also indicate changes in fluid status, as a sudden weight gain or loss may suggest fluid retention or depletion, respectively. Additionally, trends in weight changes over time can provide valuable information about the effectiveness of diuretic therapy and the patient's response to treatment.